Mode
Text Size
Log in / Sign up
N/A N=45 Randomized Treatment

Blood Flow Restriction Following ACL Reconstruction

Anterior Cruciate Ligament Rupture

Enrolled (actual)
45
Serious AEs
0.0%
Results posted
Dec 2022
Primary outcome: Primary: International Knee Documentation Committee (IKDC) Questionnaire Score — 47.40; 50.80; 61.83; 52.86 score on a scale — p=0.0219

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Blood Flow Restriction Therapy (Device); ACL Reconstruction rehabilitation (Other)
Age
Pediatric, Adult · 13+ yrs
Sex
All
Sponsor
Inova Health Care Services
Primary completion
Nov 2021

Outcome Measures

OutcomeResultp-value
PRIMARY
International Knee Documentation Committee (IKDC) Questionnaire Score
47.40; 50.80; 61.83; 52.86 0.0219 sig
PRIMARY
Visual Analog Score
2.36; 3.18; 2.72; 3.16; 1.00; 1.51 0.008 sig
PRIMARY
Quadriceps Tendon Strength
58.88; 51.35; 63.68; 66.13; 75.73; 68.51 0.011 sig
PRIMARY
Thigh Circumference
99.23; 101.62; 97.02; 97.68; 94.55; 97.11 0.223
PRIMARY
Degrees of Knee Flexion
51.54; 41.9; 76.4; 70.00; 102.02; 91.75 0.242
PRIMARY
Degrees of Knee Extension
-6.88; -5.25; -3.60; -3.20; -0.32; -0.09 0.049 sig
SECONDARY
Adverse Effects
0; 0

Summary

The main objective is to determine the impact of Blood Flow Restriction (BFR) therapy, in comparison to a standard rehabilitation protocol, on preventing atrophy, improving quadriceps strength and improving functional outcomes of patients recovering from ACL reconstruction. The investigators hypothesize that patients undergoing BFR therapy after ACL reconstruction surgery will have better functional outcomes than those undergoing normal rehabilitation without BFR therapy.

Eligibility Criteria

Inclusion Criteria

  • Age 13-35 years at the time of surgery
  • Anterior Cruciate Ligament (ACL) reconstruction
  • Using a physical therapy center with Blood Flow Restriction capabilities.

Exclusion Criteria

  • Concomitant ligament reconstruction
  • Concurrent procedures that require delayed weight bearing (ie: High Tibial Osteotomy (HTO), multi-ligament reconstruction, microfracture, etc)
  • History of Deep Vein Thrombosis (DVT)/Pulmonary Embolism (PE)
  • Immunocompromising conditions (ie: Rheumatoid arthritis, chronic steroid use, etc.)
  • History of coagulation disorders or current use of anticoagulants
  • Completion of physical therapy at a location not affiliated with the study
  • Pregnancy
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03758755). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search